Dashboard
Manage Tickers

EXAI Exscientia Plc


$ 0.15 (3.2 %)    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 611.70 $ 5.09 (0.84 %)
DIA $ 467.20 $ 1.51 (0.32 %)
SPY $ 672.21 $ 3.96 (0.59 %)
TLT $ 91.38 $ -0.63 (-0.68 %)
GLD $ 378.90 $ 1.51 (0.4 %)
$ 4.84
-- x --
-- x --
-- - --
$ 3.80 - $ 7.91
1,510,051
na
na
$ 1.32
na
TBD
na
na (na)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles
Recursion And Exscientia Receive Sharehold...
11/13/2024 14:11:47

Core News & Articles
Exscientia Announced The Advancement Of Tw...
10/16/2024 11:03:51

Both lead compounds have met the product profile requirements, set by both Exscientia and Sanofi, to enable a transition to the...

exscientia-announced-three-abstracts-to-be-presented-at-the-eortc-nci-aacr-symposium-2024
Exscientia Announced Three Abstracts To Be...
10/09/2024 11:20:25

Demonstrated combination potential for MALT1 and BTK inhibitors in models of B-cell malignanciesData highlights efficacy of ‘53...

12-health-care-stocks-moving-in-tuesdays-after-market-session
12 Health Care Stocks Moving In Tuesday's ...
10/08/2024 20:31:08

exscientia-q2-2024-gaap-eps-036-may-not-be-comparable-to-017-estimate-sales-5600-may-not-be-comparable-to-12942m-estimate
Exscientia Q2 2024 GAAP EPS $(0.36) May No...
08/15/2024 11:04:48

barclays-downgrades-exscientia-to-equal-weight-announces-5-price-target
Barclays Downgrades Exscientia to Equal-We...
08/13/2024 17:34:35

Barclays analyst Peter Lawson downgrades Exscientia (NASDAQ:EXAI) from Overweight to Equal-Weight and announces $5 price tar...

td-cowen-downgrades-exscientia-to-hold
TD Cowen Downgrades Exscientia to Hold
08/09/2024 10:38:30

TD Cowen analyst Brendan Smith downgrades Exscientia (NASDAQ:EXAI) from Buy to Hold.

ai-powered-drug-discovery-firm-exscientia-to-merge-with-nvidia-partner-recursion-pharmaceuticals
AI-Powered Drug Discovery Firm Exscientia ...
08/08/2024 21:37:28

Exscientia merges with Recursion Pharmaceuticals in an all-stock deal. The new entity, named Recursion, will focus on industria...

Core News & Articles
Recursion And Exscientia Announce Definiti...
08/08/2024 11:40:39

Expect 10 Clinical Readouts In 18 Months, $200M In Milestone Payments Over 24 Months, $20B Potentially Overall, $850M Cash On H...

barclays-maintains-overweight-on-exscientia-lowers-price-target-to-9
Barclays Maintains Overweight on Exscienti...
07/29/2024 15:27:06

Barclays analyst Peter Lawson maintains Exscientia (NASDAQ:EXAI) with a Overweight and lowers the price target from $10 to $9.

exscientia-agrees-to-acquire-gt-apeirons-share-of-its-oral-cdk7-inhibitor-program-gaining-full-control-of-gtaexs617-and-all-related-intellectual-property-to-pay-gt-apeiron-10m-upfront-cash
Exscientia Agrees To Acquire GT Apeiron's ...
07/18/2024 11:04:37

The monotherapy dose escalation phase of ELUCIDATE is designed to assess the safety, pharmacokinetics and pharmacodynamics of &...

exscientia-will-expand-its-work-with-amazon-web-services-using-the-cloud-providers-artificial-intelligence-and-machine-learning-services-to-power-its-platform-for-end-to-end-drug-discovery-and-automation
Exscientia Will Expand Its Work With Amazo...
07/10/2024 11:18:09

The platform, built using Amazon Web Services technologies, integrates generative AI drug design and robotic lab automation to ...

td-cowen-initiates-coverage-on-exscientia-with-buy-rating
TD Cowen Initiates Coverage On Exscientia ...
07/09/2024 10:59:40

TD Cowen analyst Brendan Smith initiates coverage on Exscientia (NASDAQ:EXAI) with a Buy rating.

exscientias-cash-cash-equivalents-and-short-term-bank-deposits-as-of-march-31-2024-were-4169m-which-is-expected-to-provide-cash-runway-into-2027
Exscientia's Cash, Cash Equivalents And Sh...
05/21/2024 11:06:18

exscientia-q1-2024-gaap-eps-021-beats-039-estimate-sales-6700m-miss-7509m-estimate
Exscientia Q1 2024 GAAP EPS $(0.21) Beats ...
05/21/2024 11:03:38

tesla-deciphera-pharmaceuticals-heartland-financial-and-other-big-stocks-moving-higher-on-monday
Tesla, Deciphera Pharmaceuticals, Heartlan...
04/29/2024 14:47:40

morgan-stanley-maintains-equal-weight-on-exscientia-maintains-7-price-target
Morgan Stanley Maintains Equal-Weight on E...
04/22/2024 17:20:49

Morgan Stanley analyst Vikram Purohit maintains Exscientia (NASDAQ:EXAI) with a Equal-Weight and maintains $7 price target.

why-ulta-beauty-shares-are-trading-lower-by-around-14-here-are-other-stocks-moving-in-wednesdays-mid-day-session
Why Ulta Beauty Shares Are Trading Lower B...
04/03/2024 17:56:10

Shares of Ulta Beauty, Inc. (NASDAQ: ULTA) fell sharply during Wednesday’s session amid the company's presentation at the ...

exscientia-plc-files-for-mixed-shelf-of-up-to-300m
Exscientia Plc Files For Mixed Shelf Of Up...
03/21/2024 13:25:25

– SEC Filing

12-health-care-stocks-moving-in-thursdays-pre-market-session
12 Health Care Stocks Moving In Thursday's...
03/21/2024 13:05:49

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION